Product Liability
Jul. 17, 2010
Doctors Split on Pulling Diabetes Drug
The opinions of 33 doctors and scientists regarding the safety of Avandia could help plaintiffs resolve thousands of claims against the diabetes drug's maker.
Daily Journal Staff Writer
The opinions of 33 doctors and scientists regarding the safety of Avandia could help plaintiffs resolve thousands of claims against the diabetes drug's maker.
Twelve members of a U.S. Food and Drug Administration panel recommended this week that GlaxoSmithKline's Avandia be taken off the market, since studies have shown it puts patients at greater risk for heart attacks. Seven...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In